---
title: C5-9 deficiency
date: 2024-01-01
---
# C5-9 deficiency

- Terminal complement pathway deficiency is a genetic condition affecting the complement membrane attack complex (MAC)
 
- Suspect terminal complement pathway deficiency with patients who have more than one episode of Neisseria infection.
- Patients with terminal complement pathway deficiency should receive meningococcal and pneumococcal vaccinations. They can receive live vaccines.
